Frontlight ResearchEarly access
Trial site
GHR Mulhouse Sud-Alsace
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia1 trial
- Melanoma1 trial
- Myelodysplastic syndromes1 trial
- Phase
- Phase 21 trial
- Status
- Active, not recruiting2 trials
- Lead sponsor
- Groupe Francophone des Myelodysplasies1 trial
- Institut de Cancérologie de Lorraine1 trial
Running trials
Active, not recruiting
Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL)
Active, not recruiting
IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome
Site data: ClinicalTrials.govUpdated 12 Nov 2026